Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-020141
Filing Date
2019-07-23
Accepted
2019-07-23 19:58:45
Documents
2
Period of Report
2019-07-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1562
2 EX-24 DOCUMENT attachment1.htm EX-24 4714
  Complete submission text file 0000899243-19-020141.txt   7726
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address
HANISH ARNOLD C (Reporting) CIK: 0001233253 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36812 | Film No.: 19969023

Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Issuer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations